An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer. https://www.biorxiv.org/content/10.1101/2023.07.24.550265v1?med=mas
An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer. https://www.biorxiv.org/content/10.1101/2023.07.24.550265v1?med=mas